Skip to main content
Equibles

MORGAN STANLEY

Position in ACXP — Acurx Pharmaceuticals, Inc.

CIK 895421 NEW YORK, NY
Back to ACXP Full portfolio

Position in ACXP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$11,625
-$12,490 QoQ
Shares Held
7,500
+15.4% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 19 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ACXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ACXP ranks #419 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in ACXP

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,625 7,500
2026-03-31 $24,115 6,500
2025-12-31 $16,185 6,500
2025-09-30 $22,779 5,310
2025-06-30 $54,268 106,201
2025-03-31 $41,418 106,201
2024-12-31 $86,447 106,201
2024-09-30 $87,781 46,201
2024-06-30 $104,402 46,401
2024-03-31 $64,682 26,401
2023-12-31 $62,049 16,201
2023-09-30 $22,500 15,000
2021-12-31 $12 3